{"id":2826,"date":"2016-04-22T13:16:00","date_gmt":"2016-04-22T11:07:59","guid":{"rendered":"http:\/\/oncomatryx.com\/?p=2826"},"modified":"2016-04-22T13:16:00","modified_gmt":"2016-04-22T11:07:59","slug":"new-publication-at-aspic-2016","status":"publish","type":"post","link":"https:\/\/oncomatryx.com\/es\/new-publication-at-aspic-2016\/","title":{"rendered":"New publication at the ASPIC 2016"},"content":{"rendered":"<p><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone wp-image-2819 size-full\" src=\"http:\/\/oncomatryx.com\/wp-content\/uploads\/2015\/07\/banner_2nd_congress_1.jpg\" alt=\"Aspic oncomatryx\" width=\"760\" height=\"250\" \/><\/p>\n<h2><span style=\"color: #99ccff;\"><strong>Poster presentation at the 2nd ASPIC\u00a0 International Congress. 28-29 April, 2016<strong>. Porto. Portugal.<\/strong><\/strong><\/span><\/h2>\n<h2>We are pleased to inform you that\u00a0Enrique De Alava team from Hospital Virgen del Roc\u00edo, Sevilla, Spain, will present the<span class=\"il\"> poster<\/span> Targeting Ewing Sarcoma Cells and the tumor microenvironment\u00a0with OMTX003 Anti-Endoglin Monoclonal Antibodies\u201d\u00a0at the ASPIC, with the results obtained from research work performed in collaboration with Oncomatryx.<\/h2>\n","protected":false},"excerpt":{"rendered":"<p>Poster presentation at the 2nd ASPIC\u00a0 International Congress. 28-29 April, 2016. Porto. Portugal. We are pleased to inform you that\u00a0Enrique De Alava team from Hospital Virgen del Roc\u00edo, Sevilla, Spain, will present the poster Targeting Ewing Sarcoma Cells and the tumor microenvironment\u00a0with OMTX003 Anti-Endoglin Monoclonal Antibodies\u201d\u00a0at the ASPIC, with the results obtained from research work &#8230; <a title=\"New publication at the ASPIC 2016\" class=\"read-more\" href=\"https:\/\/oncomatryx.com\/es\/new-publication-at-aspic-2016\/\" aria-label=\"Leer m\u00e1s sobre New publication at the ASPIC 2016\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":3,"featured_media":2835,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[18],"tags":[],"class_list":["post-2826","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/posts\/2826","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/comments?post=2826"}],"version-history":[{"count":0,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/posts\/2826\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/media?parent=2826"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/categories?post=2826"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/tags?post=2826"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}